CloudLIMS, a leading provider of laboratory informatics, hosted a complimentary webinar to discuss how laboratories can accelerate COVID-19 testing and issue results securely to healthcare wallets. Several attendees, including laboratory managers, owners, and quality managers of COVID-19 diagnostic laboratories participated in the webinar. We received several interesting questions related to workflow automation, compliance, test result validation, and test report delivery to patients.
Currently, several countries are battling the second and even third wave of COVID-19 forcing lockdowns in many. COVID-19 diagnostic laboratories across the globe need to boost testing and minimize turnaround time so that those who test positive can isolate themselves and stop the spread. The webinar discussed how COVID-19 diagnostic laboratories can leverage Cloud and Mobile Technology to greatly improve their capacity for COVID-19 testing. Furthermore, the webinar illustrated how laboratories can adapt to surges in demand and how Mobile Healthcare Wallets massively improve the issuance process, giving patients a secure and convenient way of asserting their health credentials.
The topics covered in the webinar include:
How COVID-19 diagnostic laboratories can leverage automation to increase testing throughput.
How COVID-19 testing laboratories can securely manage data and follow compliance with ease.
Introducing healthcare wallets for offering direct to patient services.
How Digital ID verification and Artificial Intelligence work counterfeit fraud.
The webinar is now available on-demand. If you missed the chance to attend the live webinar, you can watch the recording.
Is Your COVID-19 Diagnostic Testing Lab Struggling with a High Rate of False-Negative Results? Read our blog to learn how to overcome this challenge.
Also, watch a 2-minute video to see how CloudLIMS, a full-feature COVID-19 LIMS, can help you manage laboratory data, automate and streamline workflows, generate custom test reports as per FDA and CDC guidelines, and follow regulatory guidelines with ease.